Bioxytran (BIXT) EBT Margin Growth (5y) (2015 - 2018)
Bioxytran (BIXT) EBT Margin Growth (5y) (2015 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Bioxytran | 2.47 Mn | 2.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 64,477.00 |
| Mar 31, 2018 | 84,717.00 |
| Dec 31, 2017 | 85,562.00 |
| Sep 30, 2017 | 495,500.00 |
| Jun 30, 2017 | -9,900.00 |
| Mar 31, 2017 | -51,037.00 |
| Dec 31, 2016 | 1.13 Mn |
| Sep 30, 2016 | 241,014.00 |
| Jun 30, 2016 | 15,283.00 |
| Mar 31, 2016 | 1.61 Mn |
| Dec 31, 2015 | 116,413.00 |
| Sep 30, 2015 | 417,428.00 |